您的位置: 首页 > 农业专利 > 详情页

3-(2,6-二氯-3,5-二甲氧基-苯基)-1-{6-[4-(4-乙基-哌嗪-1-基)-苯基氨基]-嘧啶-4-基}-1-甲基-脲及其鹽的晶型
专利权人:
Novartis AG
发明人:
BERGHAUSEN, Joerg,KAPA, Prasad, Koteswara,MCKENNA, Joseph,SLADE, Joel,WU, Raeann,DU, Zhengming,STOWASSER, Frank
申请号:
HK12111776.3
公开号:
HK1171016B
申请日:
2012.11.19
申请国别(地区):
HK
年份:
2016
代理人:
摘要:
The present technology provides novel anhydrous and hydrated crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea, amorphous and anhydrous crystalline polymorphs of its monophosphoric acid salt, and the hydrochloride salt, including its dihydrate. The present technology further provides methods for preparing the various forms, compositions containing them, and methods of treatment employing them.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充